Global Veterinary Pain Management Market Size study & Forecast, by Product (NSAIDs, Anesthetics, Opioids, Others), by Indication (Osteoarthritis, Post-operative pain, Others), by Animal Type (Livestock Animal, Companion Animal), by End User (Hospitals & C

Global Veterinary Pain Management Market Size study & Forecast, by Product (NSAIDs, Anesthetics, Opioids, Others), by Indication (Osteoarthritis, Post-operative pain, Others), by Animal Type (Livestock Animal, Companion Animal), by End User (Hospitals & Clinics, Others) and Regional Analysis, 2022-2029

Global Veterinary Pain Management Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Veterinary pain management is a medical approach that is draws towards diagnosis, prevention, and treatment of pain among veterinary, which are caused by factors including surgical procedures, internal organ problems, slipped disc, arthritis, physical trauma, and joint damage. The growth in companion animal population, rising animal healthcare expenditure, and increasing number of veterinary practitioners in developed economies

The rising emphasis on animal healthcare is leveraging the growth of the global market. According to Statista, the global animal health market has significant increase with an estimated value of USD 28.9 billion from 2018 to 33.7 billion in 2021. Therefore, the growing expenditure on providing better healthcare services to animals is exhibiting a positive influence on market growth. Moreover, the high popularity of non-conventional and non-pharmaceutical treatment techniques and increasing technological advancements and innovation are creating growth prospects to the market in the impending years. However, rising pet care costs and stringent regulatory process are hindering stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Veterinary Pain Management Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the space in terms of revenue, owing to the increasing investment in animal healthcare facilities and rising presence of skilled professionals and leading market players. Whereas, Asia Pacific is expected to grow significantly during the forecast period. Factors such as rising prevalence of animal diseases, as well as increasing adoption of pets are burgeoning the market growth in the forecasting years.

Major market player included in this report are:
Boehringer Ingelheim International GmbH
Zoetis Inc.
Elanco Animal Health Incorporated
Merck & Co., Inc.
Dechra Pharmaceuticals
Vetoquinol
SeQuent Scientific Limited
Norbrook Laboratories Limited
Ceva Santé Animale
Chanelle Pharma

Recent Developments in the Market:
 In December 2018, Merck declared the acquisition of Antelliq with the objective of enhancing their animal vaccines and pharmaceutical portfolio.
 In January 2018, Elanco publicized that the company received European approval for its marketing and selling of the product Galliprant across the European region.
 In January 2018, Dechra Pharmaceuticals announced that the company acquired Le Vet and Ast Farma, which aims on to expanding its business operations across the Netherlands and Europe.

Global Veterinary Pain Management Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Product, Indication, Animal Type, End User, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
NSAIDs
Anesthetics
Opioids
Others
By Indication:
Osteoarthritis
Post-operative pain
Others
By Animal Type:
Livestock Animal
Companion Animal
By End User:
Hospitals & Clinics
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Companies Mentioned

Boehringer Ingelheim International GmbH
Zoetis Inc.
Elanco Animal Health Incorporated
Merck & Co., Inc.
Dechra Pharmaceuticals
Vetoquinol
SeQuent Scientific Limited
Norbrook Laboratories Limited
Ceva Santé Animale
Chanelle Pharma

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.